Additionally, pathways associated with the excretory system, endocrine and metabolic diseases, cardiovascular diseases, and signaling molecules and interactions were significantly enriched in the KLRD1 high-expression group (Figure 4B). This evidence concerns the gene KLRD1 and metabolic disease.